Milad Abdalla: Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
Milad Abdalla, Medical Laboratory Technologist at Al Yalayis Government Transactions Center, shared a post on LinkedIn:
“Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
Accurate diagnostics start long before the sample reaches the analyzer. The pre‑analytical phase – especially the Order of Draw and proper Blood Culture collection – remains one of the most critical determinants of result integrity.
Why It Matters?
Additive carryover can alter results, delay diagnosis, and compromise patient safety. That’s why the CLSI sequence is the global benchmark for preventing contamination and ensuring reliable outcomes.
CLSI Order of Draw (Simplified)
- Blood Cultures — Always first to maintain sterility and avoid additive interference.
- Light Blue – Citrate — Coagulation tests requiring precise 1:9 ratio.
- Serum Tubes – Red/Gold/SST — Chemistry, serology, immunology.
- Green – Heparin — STAT chemistry and blood gases.
- Lavender – EDTA — CBC, HbA1c; collected late to avoid metal chelation interference.
- Grey – Fluoride/Oxalate — Glucose and lactate; strong inhibitors, so always last.
Blood Cultures – The First Line in Infection Diagnosis
Their accuracy depends on:
- Strict aseptic technique
- Correct blood volume
- Drawing them before any other tube
Key Takeaways
- Sterility first — Blood cultures always lead the sequence.
- Prevent additive carryover — Follow CLSI strictly.
- Volume accuracy — Especially for coagulation and cultures.
- Continuous competency — Phlebotomy excellence is a global responsibility.
By mastering these fundamentals, we elevate diagnostic accuracy and strengthen patient safety across healthcare systems worldwide.”

Stay updated with Hemostasis Today.
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:14Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell
-
Sep 2, 2026, 23:50Shashank Joshi: Individualized vs. Standard BP Control Shows Similar 90-Day Outcomes
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union
-
Sep 2, 2026, 18:18Katie Gonzalez: Understanding the Hidden Risk of Inherited Thrombophilias